Right heart condition in patients with COVID-19 pneumonia

Right heart condition in patients with COVID-19 pneumonia

Aim. To assess right heart condition in patients with coronavirus disease 2019 (COVID-19) pneumonia.Material and methods. One hundred and five patients with COVID-19 pneumonia were divided into 3 groups depending on the involvement of lung parenchyma: group I — 0-25%, II — 25-50%, III — 50-75%. The...

Full description

Bibliographic Details
Main Authors:	N. G. Poteshkina, N. S. Krylova, A. A. Karasev, T. A. Nikitina, A. M. Svanadze, I. P. Beloglazova, E. A. Kovalevskaya, K. A. Barakhanov, M. A. Lysenko, A. M. Ibragimova, V. N. Smorshchok
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2021-12-01
Series:	Российский кардиологический журнал
Subjects:	covid-19 echocardiography nt-probnp right heart global longitudinal strain
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4733

Similar Items

Impact of obesity on echocardiographic parameters and N-terminal pro-brain natriuretic peptide levels in patients with heart failure with mid-range ejection fraction: unanswered questions
by: E. A. Lyasnikova, et al.
Published: (2021-07-01)

Prognostic superiority of global longitudinal strain beyond four-tiered ventricular hypertrophy in asymptomatic individuals
by: Kuo-Tzu Sung, et al.
Published: (2022-08-01)

Dynamics of global and segmental strain as a marker of right ventricular contractility recovery in patients after COVID-19 pneumonia
by: N. E. Shirokov, et al.
Published: (2023-02-01)

N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs
by: I G Kirillova, et al.
Published: (2016-05-01)

The clinical value of determination of natriuretic peptides in acute coronary syndrome
by: Ekaterina Viktorovna Shreyder, et al.
Published: (2010-09-01)

HEART FAILURE IN SYSTEMIC LUPUS ERYTHEMATOSUS: RISK FACTORS AND DIAGNOSTIC FEATURES
by: T. A. Panafidina, et al.
Published: (2018-07-01)

Serum NT-proBNP levels as a marker for cardiopulmonary function in preeclampsia
by: H.M. Kim, et al.
Published: (2020-08-01)

Prognostic Impact of Global Longitudinal Strain and NT-proBNP on Early Development of Cardiotoxicity in Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy
by: Gintare Muckiene, et al.
Published: (2023-05-01)

Investigating the diagnostic accuracy of vertebral heart score, vertebral left atrium score and thoracic width measurement in cats with suspected cardiac problems
by: B. Ozdil, et al.
Published: (2025-03-01)

Cardiac biomarkers for screening and prognostication of cardiac dysfunction in critically ill patients
by: Oscar Cavefors, et al.
Published: (2024-12-01)

Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01)

Characteristics of patients with chronic heart failure in different age groups
by: R. I. Jafarov, et al.
Published: (2023-05-01)

Biomarkers of heart failure: current state of problem
by: O. P. Ishevskaia, et al.
Published: (2021-12-01)

Level and correlations of soluble suppression of tumorigenicity 2 protein in heart failure and its relationship with clinical and paraclinical characteristics of patients
by: A. Ya. Kravchenko, et al.
Published: (2022-06-01)

Prognostic value of temporal patterns of global longitudinal strain in patients with chronic heart failure
by: Sabrina Abou Kamar, et al.
Published: (2023-01-01)

Association of Pro‐B‐Type Natriuretic Peptide With Cardiac Magnetic Resonance–Measured Global and Regional Cardiac Function and Structure Over 10 Years: The MESA Study
by: Amir Ali Rahsepar, et al.
Published: (2021-04-01)

Role of Serum NT-proBNP Levels in Early Prediction of Prognosis in Severe COVID-19 Pneumonia
by: Hanife Usta Atmaca, et al.
Published: (2023-11-01)

The importance of NT proBNP in hypertensive patients management for preventing heart failure
by: Irina Cuciureanu, et al.
Published: (2021-03-01)

Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke
by: S. A. Mekhryakov, et al.
Published: (2020-12-01)

N-terminal fragment of the brain natriuretic peptide and proinflammatory cytokines in patients with coronary heart diseas
by: S V Shalaev, et al.
Published: (2009-05-01)

Assessment of N-terminal pro-brain natriuretic peptide in patients with arrhythmia due to undifferentiated connective tissue disease
by: E. N. Loginova, et al.
Published: (2023-11-01)

Diagnostic Significance of the Level of Soluble Stimulating Growth Factor in Patients with Spondyloarthritis as an Early Marker of Cardiovascular Pathology
by: K. D. Dorogoykina, et al.
Published: (2022-05-01)

Comparison Of Pro-BNP Levels And Myocardial Performance Index Before And After Iron Treatment In Children With Congenital Cyanotic Heart Disease With Iron Deficiency Anemia
by: Adnan Barutçu, et al.
Published: (2019-09-01)

Kalp Hastalığı Olmayan Romatoid Artritli Hastalarda Hastalık Aktivitesi İle NT-pro BNP Düzeyleri Arasındaki İlişki
by: Bülent Bütün, et al.
Published: (2019-01-01)

Serum Ürik Asit Düzeyinin Kardiyak Disfonksiyonda Prognostik bir Önemi Var mıdır?
by: Canan Topçuoğlu, et al.
Published: (2018-09-01)

Clinical correlation between N-terminal pro-b-type natriuretic peptide and angiographic coronary atherosclerosis
by: Demóstenes G.L. Ribeiro, et al.
Published: (2014-06-01)

Cardiac function in pregnant women with preeclampsia
by: Gülen Yerlikaya-Schatten, et al.
Published: (2024-12-01)

Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics
by: Mădălina Ioana Moisi, et al.
Published: (2020-03-01)

PREDICTORS OF CONTINUOUS HOSPITAL STAY IN ADULT PATIENTS WITH ACQUIRED VALVULAR DISEASE, OPERATED WITH HYPOTHERMIC AND NORMOTHERMIC CARDIOPULMONARY BYPASS
by: D. G. Shakhin, et al.
Published: (2017-12-01)

Subclinical dysfunction of remote myocardium is related to high NT-proBNP and affects global contractility at follow-up, independently of infarct area
by: Giovanni Diana, et al.
Published: (2022-12-01)

BRAIN NATRIURETIC PROPEPTIDE AS A MARKER OF THE HEART DAMAGE IN METABOLIC SYNDROME
by: R. A. Libis, et al.
Published: (2015-04-01)

Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction
by: V. I. Podzolkov, et al.
Published: (2020-09-01)

Prognostic and diagnostic significance of the cardiac biomarker NT-proBNP in the perioperative period of vascular surgery procedures
by: I. A. Kozlov, et al.
Published: (2023-10-01)

Correlation of NT-proBNP levels with clinical and echocardiographic features in evaluation of patients admitted with heart failure
by: Dhinakaran K, et al.
Published: (2023-12-01)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
by: Li H, et al.
Published: (2020-02-01)

CLINICAL VALUE OF DETERMINING GALECTIN-3 IN PATIENTS WITH CHRONIC HEART FAILURE
by: K. A. Gyamdzhyan, et al.
Published: (2017-12-01)

IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
by: I. G. Kirillova, et al.
Published: (2018-07-01)

Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy
by: I. G. Kirillova, et al.
Published: (2020-03-01)

Detection of right ventricular dysfunction by three – dimensional echocardiography and two - dimensional speckle tracking in breast cancer patients receiving anthracycline- based chemotherapy
by: Wafaa S. El-Sherbeny, et al.
Published: (2023-04-01)

BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01)